Najmeh Moradi, et al. “Economic Evaluation of Infliximab for Treatment of Refractory Ulcerative Colitis in Iran: Cost-Effectiveness Analysis: Economic Evaluation of Infliximab in UC Patients”. Iranian Journal of Pharmaceutical Sciences, vol. 12, no. 4, Oct. 2016, pp. 33-42, doi:10.22037/ijps.v12.40711.